Dr. Fortino Earns the WebMD Patients’ Choice Award

FOR IMMEDIATE RELEASE

Dr. Robert Fortino Awarded WebMD Patients’ Choice Award and Preferred Provider Distinction in Philadelphia

PHILADELPHIA, PA & TURNERSVILLE, NJ, October 22, 2026 . Dr. Robert Fortino, a board-certified internal medicine physician and Doctor of Osteopathic Medicine, has received the WebMD Patients’ Choice Award in WebMD’s Endocrinology, Diabetes & Metabolism category for Philadelphia, along with designation as a WebMD Preferred Provider.

WebMD’s Patients’ Choice Award is based on patient satisfaction ratings, comparing a provider’s 4 and 5-star ratings with others in the same specialty and region. The Preferred Provider badge recognizes providers who are committed to transparency, responsiveness, and great service to patients, and who have earned a high patient satisfaction rating. More on how both are awarded is available in WebMD’s awards methodology.

With nearly 30 years in medical weight loss, Dr. Fortino founded one of the region’s first medical weight loss practices, bringing a hands-on, whole-person osteopathic approach to long-term health. From offices in Philadelphia and South Jersey, he provides physician-supervised care for patients across Philadelphia, Camden County, and Gloucester County.

“Receiving this recognition directly from our patients through WebMD means a great deal to our team,” said Dr. Fortino. “Real metabolic care takes time. It shouldn’t be rushed, and it shouldn’t be handled by an algorithm or an automated app. Our approach has always been to sit down with each patient, review their full medical history, run the right diagnostic tests, and build a plan that works for their life. This recognition reflects the trust our patients place in us every day.”

Dr. Fortino’s practice pairs in-office evaluations with tailored medical and lifestyle care:

  • Physician-Led Medical Weight Loss & Metabolic Nutrition: In-office seca body composition scans track fat and lean muscle, so treatment plans can be adjusted to help protect muscle. Plans include metabolic nutrition counseling designed to support metabolic health and energy.
  • GLP-1 Weight Loss Treatment: Tailored dosing guided by a “start low, advance slow” approach, adjusted gradually to the lowest effective dose. Close monitoring and proactive side effect management continue throughout care, along with a planned exit strategy from the first visit.
  • Testosterone Replacement Therapy (in person): Physician-supervised care guided by comprehensive lab work, which may help address symptoms associated with low testosterone and support metabolic health.
  • Vitamin & Lipotropic Injections: In-office injections, including Super B12 and glutathione.

This recognition joins the practice’s 2026 Philly Favorites Gold Winner for Weight Loss Center award (The Philadelphia Inquirer). Dr. Fortino is a member of the Obesity Medicine Association (OMA), The Obesity Society (TOS), the American Medical Association (AMA), the American Osteopathic Association (AOA), and the New Jersey Association of Osteopathic Physicians and Surgeons (NJAOPS).

To learn more about physician-supervised medical weight loss or to schedule a New Patient Evaluation, visit drfortino.net or call either office directly.

About Dr. Robert Fortino, Medical Weight Loss Center

Dr. Robert Fortino, Medical Weight Loss Center provides physician-supervised medical weight loss, hormone therapy, and metabolic health care in Philadelphia and South Jersey. Founded by Dr. Fortino as one of the region’s first medical weight loss practices, the practice focuses on in-person evaluations, careful medication management, direct physician oversight, and practical nutrition guidance for long-term health.

Media & Patient Inquiries:
Dr. Robert Fortino, Medical Weight Loss Center

WebMD Preferred Provider
WebMD Patients Choice Award

Disclaimer: The information in this release is intended solely for educational and informational purposes and does not constitute formal medical advice, diagnosis, or treatment. Individual clinical outcomes, prescription eligibility, and therapeutic protocols are determined through comprehensive physician evaluation and medical history review.